Mayne Pharma reported $4.24M in Interest Expense on Debt for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Ansell ANN:AU $ 8.4M 300K
Cochlear COH:AU $ 4.3M 700K
CSL CSL:AU $ 67.8M 11.3M
Ecofibre Ltd EOF:AU 640K 17K
Healius Ltd HLS:AU $ 25.3M 2M
Nanosonics Ltd NAN:AU $ 230K 57K
Polynovo Ltd PNV:AU 270.67K 219.94K
Probiotec Ltd PBP:AU 2.13M 128.81K
Sigma Healthcare Ltd SIG:AU 5.61M 379K
Sonic Healthcare SHL:AU $ 40.28M 892K
Telix Pharmaceuticals Ltd TLX:AU 89K 15K